Tarek Taha

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Prognostic Factors

Ejection Fraction

Top Venues

NPJ precision oncology

Pediatric hematology and oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Moshe Elkabets, Tarek Taha, Orli Abramov, Yaniv Zohar, Kamel Mhameed, Ofir Cohen, Angel Porgador, Moshe Elkabets, Salem Billan
PD1 ligand functionality a biomarker of response to anti PD1 treatment in patients with HNSCC. NPJ precision oncology 8 (1) (2024)
Moshe Elkabets, Tarek Taha, Orli Abramov, Yaniv Zohar, Kamel Mhameed, Ofir Cohen, Angel Porgador, Moshe Elkabets, Salem Billan
PD1 ligand functionality a biomarker of response to anti PD1 treatment in patients with HNSCC. NPJ precision oncology 8 (1) (2024)
Moshe Elkabets, Tarek Taha, Orli Abramov, Yaniv Zohar, Kamel Mhameed, Ofir Cohen, Angel Porgador, Moshe Elkabets, Salem Billan
PD1 ligand functionality a biomarker of response to anti PD1 treatment in patients with HNSCC. NPJ precision oncology 8 (1) (2024)
Tarek Taha, Hosam Abu-Sini, Salem Billan
Tyrosine kinase inhibitor treatment and long-term follow-up for metastatic malignant struma ovarii. Pediatric hematology and oncology 39 (8) (2022)